Dalfampridine: A Bioactive Compound for Improvement in Patients with Multiple Sclerosis

Multiple sclerosis (MS) is known as chronic autoimmune, inflammatory neurological disorder of the central nervous system which may cause progressive walking impairment which results to disability, loss of independence and diminished quality of life. Dalfampridine (4-aminopyridine), a voltagedependent potassium channel blocker, has been shown to improve walking in patients with MS, as demonstrated by an increase